ID: ALA5198644

Max Phase: Preclinical

Molecular Formula: C21H18F5NO2

Molecular Weight: 411.37

Associated Items:

Representations

Canonical SMILES:  O=C1Nc2c(C(F)(F)F)cccc2[C@]1(c1ccc(O)cc1)C1CCC(F)(F)CC1

Standard InChI:  InChI=1S/C21H18F5NO2/c22-19(23)10-8-13(9-11-19)20(12-4-6-14(28)7-5-12)15-2-1-3-16(21(24,25)26)17(15)27-18(20)29/h1-7,13,28H,8-11H2,(H,27,29)/t20-/m0/s1

Standard InChI Key:  QANUARHUGRNNRY-FQEVSTJZSA-N

Associated Targets(Human)

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T47D 39041 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-436 532 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HT-29 80576 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 411.37Molecular Weight (Monoisotopic): 411.1258AlogP: 5.47#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.48CX Basic pKa: CX LogP: 4.97CX LogD: 4.96
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.64Np Likeness Score: 0.11

References

1. Boudreau MW, Mulligan MP, Shapiro DJ, Fan TM, Hergenrother PJ..  (2022)  Activators of the Anticipatory Unfolded Protein Response with Enhanced Selectivity for Estrogen Receptor Positive Breast Cancer.,  65  (5.0): [PMID:35080871] [10.1021/acs.jmedchem.1c01730]

Source